THYROID EYE DISEASE
Clinical trials for THYROID EYE DISEASE explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cholesterol drug shrink eye muscle swelling in thyroid eye disease?
Disease control Not yet recruitingThis trial tests whether adding atorvastatin, a common cholesterol-lowering drug, to the standard steroid treatment can better reduce eye muscle swelling in people with moderate-to-severe thyroid eye disease. Half of the participants will receive the standard steroid alone, while…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1 • Sponsor: Banu Aji Dibyasakti • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new drug ease bulging eyes in thyroid disease?
Disease control Not yet recruitingThis phase 3 trial tests whether the experimental drug KHN939 can reduce eye bulging and other symptoms in people with moderate-to-severe active thyroid eye disease. About 60 participants in China will receive either KHN939 or a placebo by infusion every three weeks for 21 weeks.…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Beijing Kanghong Biological Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can an experimental drug reduce eye bulging in thyroid eye disease?
Disease control Not yet recruitingThis phase 3 trial is testing whether the experimental drug KHN939 can reduce eye bulging in people with moderate-to-severe inactive thyroid eye disease. About 117 participants in China will receive either KHN939 or a placebo by infusion every three weeks for 21 weeks. The main g…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Beijing Kanghong Biological Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug NTB003 aims to reduce bulging eyes in thyroid disease
Disease control Not yet recruitingThis early-stage trial tests a new drug called NTB003 in 74 people with thyroid eye disease, a condition that can cause bulging eyes and inflammation. Participants receive injections of NTB003 or a placebo every 4 weeks. The study measures whether the drug reduces eye bulging and…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could fewer infusions tame thyroid eye disease?
Disease control Not yet recruitingThis study compares a shortened 4-infusion course of the drug Teprotumumab (Tepezza) against the standard 8-infusion course for people with active thyroid eye disease. Only patients who show a good early response will be eligible for the shorter regimen. The goal is to see if few…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Your phone camera could soon spot eye disorders
Diagnosis Not yet recruitingThis study will check if an AI system can accurately measure eye movements from smartphone videos. About 1,000 adults with suspected eye movement issues will record a short video while following a moving target. The AI's measurements will be compared to expert ratings to see if i…
Matched conditions: THYROID EYE DISEASE
Sponsor: THYROSCOPE INC. • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC